Update Regarding the Importation of Prescription Drugs: Canadian Importer, President Plead Guilty

In March 2018, I wrote concerning the legal risks and hazards attendant importing prescription drugs into the United States from other countries.¹  I noted the political cross-currents surrounding this activity: On the one hand, there is the natural desire by U.S. medical practitioners and patients to take advantage of the cheaper prices offered for comparable drugs in foreign countries, notably Canada, with which we share a common border.  Indeed, Congress has repeatedly explored ways to make such foreign drugs available to U.S. residents.